ENG mutations have been causally implicated in hereditary haemorrhagic telangiectasia type 1, pre‐clinical models implicate lack of ENG with eccentric LV remodelling and reduced LVEF,31 and anti‐ENG antibody has been tested in clinical trials of cancer treatment.32 Here, ENG is linked to cancer.